• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB
Click for more information
2.90% 33.5¢

DIMERIX LIMITED

Market Cap $184.1M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing new therapies in areas with unmet medical needs for global markets. It is focused on developing its products, DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its DMX-200 and DMX-700 are identified using its assay, Receptor Heteromer Investigation Technology (Receptor-HIT), which is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. It has completed two Phase 2 studies: one in FSGS and one in diabetic kidney disease. Receptor-HIT is licensed to Excellerate Bioscience.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB
Dimerix (ASX: DXB) Discussion Thread
9 10 11
07/05/24 640 206K
07/05/24 Last post  singhgu Comments Created with Sketch.  640  Views Created with Sketch.  206K 
DXB
Ann: Notification regarding unquoted securities - DXB 		07/05/24 0 392
07/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  392 
DXB
Ann: Dimerix Receives PIP Approval from the UK MHRA 		06/05/24 42 16K
TRENDING NEWS

Access the latest Thematics Insights Report: What it takes to get a new drug to market in Australia

Read More   right-arrow Created with Sketch.
NEWS
08 May 2024
06/05/24 Last post  ExtraPace Comments Created with Sketch.  42  Views Created with Sketch.  16K 
DXB
DXB - Research & Valuation 		04/05/24 19 6.9K
04/05/24 Last post  unitfree2 Comments Created with Sketch.  19  Views Created with Sketch.  6.9K 
DXB
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference
2
02/05/24 72 21K
02/05/24 Last post  BT6487 Comments Created with Sketch.  72  Views Created with Sketch.  21K 
DXB
Ann: Proposed issue of securities - DXB 		02/05/24 7 2.1K
02/05/24 Last post  RYNZN Comments Created with Sketch.  7  Views Created with Sketch.  2.1K 
DXB
DXB Media thread.
2 3
01/05/24 127 52K
01/05/24 Last post  NiceRoger Comments Created with Sketch.  127  Views Created with Sketch.  52K 
DXB
News: DXB Dimerix Receives PIP Approval From UK Medicines And Healthcare Products Regulatory Agency 		01/05/24 0 129
01/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  129 

See All Discussions arrow Created with Sketch.

Timeline

Notification regarding unquoted securities - DXB
07 May 16:11
 
Proposed issue of securities - DXB
02 May 09:44
 
Dimerix Receives PIP Approval from the UK MHRA
01 May 08:36
 
Application for quotation of securities - DXB
30 Apr 10:00
 
Application for quotation of securities - DXB
22 Apr 11:21
 
Quarterly Appendix 4C and Activities Report
22 Apr 08:45
 
View More arrow Created with Sketch.

Featured News

MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
AWJ Auric sends off first gold to Perth Mint of 2024
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.

(20min delay)
Last
33.5¢ 		Change
-0.010(2.90%) 		Mkt cap ! $184.1M
Open High Low Value Volume
34.5¢ 35.3¢ 33.5¢ $937.3K 2.718M

Buyers (Bids)

No. Vol. Price($)
7 264489 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 16720 1
View Market Depth
Last trade - 16.10pm 08/05/2024 (20 minute delay) ?
Last
34.0¢ 		  Change
-0.010 ( 0.26 %)
Open High Low Volume
34.5¢ 35.5¢ 34.0¢ 1306203
Last updated 15.42pm 08/05/2024 ?
DXB (ASX) Chart

Top Stories

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production Alara Resources has set itself up nicely in Oman to capitalise on an expected 75% surge in copper prices over the next two years.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.

Featured News

AWJ Auric sends off first gold to Perth Mint of 2024
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.